Regenx Tech Corp.'s U.S. ticker was moved from the OTCQB Venture Market to the OTC Expert Market on May 18, 2026, due to delays in filing audited financial statements for fiscal 2025. This reassignment restricts public trading on major U.S. retail platforms like Charles Schwab and Robinhood, limiting transactions to professional investors. The company remains under a cease trade order in Canada, with trading halted on the Canadian Securities Exchange. Regenx is working with its auditors to complete the delayed audit, but no completion date is set. Normal trading will resume only after the audit is filed, the cease trade order is lifted, and the company reapplies for higher-tier market listing.
Leading Japanese companies, startups, and research institutions are developing specialized AI models using NVIDIA Nemotron open models to address Japan's unique language, industrial, and workforce challenges. These AI applications range from enterpri...
ARCpoint Inc. announced it will likely miss the July 29, 2026 deadline to file its annual financial statements and related reports due to a lack of funds to pay auditors. The company has applied for a Management Cease Trade Order (MCTO) and awaits ap...
The Rosen Law Firm is investigating potential securities claims against Putnam Investment Management, LLC, alleging that the company may have provided misleading business information to investors. Investors who purchased Putnam stock-based mutual fun...
Ondo Global Markets reached $1 billion in total value locked (TVL) for tokenized stocks by May 2026, with projections to hit $5 billion by year-end. USDC, Circle's stablecoin, is the preferred settlement currency for these tokenized equities, favored...
Ademi LLP is investigating GPGI for potential securities fraud related to alleged inaccurate statements about its financials and business operations, especially concerning its acquisition of Husky Technologies Limited. This probe could impact investo...
